Racially Incongruent Ads for Food Choices

Phase-Based Progress Estimates
NYU Langone Health, New York, NY
Food Choices
Racially Incongruent Ads - Behavioral
< 18
All Sexes
What conditions do you have?

Study Summary

This is a randomized trial to examine the influence of race-congruent food marketing on social media among Black and White adolescents.

Treatment Effectiveness

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 15 minutes

15 minutes
Attitude Toward Ad
Number of Calories Purchased
Time Spent Viewing Ad

Trial Safety

Trial Design

2 Treatment Groups

Condition 2: Race Incongruent Ads
1 of 2
Condition 1: Race Congruent Ads
1 of 2
Experimental Treatment

1252 Total Participants · 2 Treatment Groups

Primary Treatment: Racially Incongruent Ads · No Placebo Group · N/A

Condition 2: Race Incongruent Ads
Experimental Group · 1 Intervention: Racially Incongruent Ads · Intervention Types: Behavioral
Condition 1: Race Congruent Ads
Experimental Group · 1 Intervention: Racially Congruent Ads · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 15 minutes
Closest Location: NYU Langone Health · New York, NY
Photo of NYU Langone Health 1Photo of NYU Langone Health 2Photo of NYU Langone Health 3
2020First Recorded Clinical Trial
1 TrialsResearching Food Choices
107 CompletedClinical Trials

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,235 Previous Clinical Trials
748,594 Total Patients Enrolled
Marie Bragg, PhDPrincipal InvestigatorNYU Langone Health

Eligibility Criteria

Age < 18 · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are between 13 and 17 years of age.
You are non-Latino White or only Black/African American.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.